GLI2 and neoplasm: Conversely, conditional Rosa26 knock-in allele of GLI3T, which was proven to downregulate GLI1 and GLI2 expression in NIH 3T3 cells, resulted in reduced PANIN lesion formation, reduced proliferative pancreatic cells (absence of Ki67 staining), and delayed PDAC tumor formation.